[PDF][PDF] Population pharmacokinetics/pharmacodynamics of docetaxel in phase II studies in patients with cancer.

…, V Valero, JR Rigas, AD Seidman, B Chevallier… - Journal of clinical …, 1998 - Citeseer
Conclusion: First-course docetaxel PK is a predictor of first-course hematologic toxicity, but
also of fluid retention, which is cumulative in nature. Patients with elevated hepatic enzymes …

Safety and reactogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with …

B Chevallier, T Vesikari, J Brzostek… - The Pediatric …, 2009 - journals.lww.com
Background: Licensed pneumococcal conjugate vaccine (7vCRM) is usually coadministered
with combination vaccines in pediatric immunization programs. Reactogenicity and safety …

Inflammatory breast cancer: pilot study of intensive induction chemotherapy (FEC-HD) results in a high histologic response rate

B Chevallier, H Roche, JP Olivier… - American journal of …, 1993 - journals.lww.com
Abstract Between July 1988 and May 1990, we treated 45 women with newly diagnosed,
unilateral, nonmetastatic, inflammatory breast cancer with an intensive neoadjuvant …

Spring-mass model characteristics during sprint running: correlation with performance and fatigue-induced changes

JB Morin, T Jeannin, B Chevallier… - International journal of …, 2006 - thieme-connect.com
Spring-mass model properties of eight non-specialized male runners were measured during
four straight 100-m sprints on an athletics track. A recently developed simple measurement …

Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM …

T Vesikari, J Wysocki, B Chevallier… - The Pediatric …, 2009 - journals.lww.com
Background: The immunogenicity of the 10-valent pneumococcal nontypeable Haemophilus
influenzae protein D-conjugate vaccine (PHiD-CV) was assessed and compared with the 7 …

Clinical and Molecular Study of 320 Children With Marfan Syndrome and Related Type I Fibrillinopathies in a Series of 1009 Probands With Pathogenic FBN1 …

…, C Stheneur, C Binquet, E Gautier, B Chevallier… - …, 2009 - publications.aap.org
From a large series of 1009 probands with pathogenic FBN1 mutations, data for 320
patients< 18 years of age at the last follow-up evaluation were analyzed (32%). At the time of …

[HTML][HTML] Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological …

MS Aapro, FH Van Wijk, G Bolis, B Chevallier… - Annals of …, 2003 - Elsevier
Background Combination chemotherapy yields better response rates which do not always
lead to a survival advantage. The aim of this study was to investigate whether the reported …

Docetaxel is a major cytotoxic drug for the treatment of advanced breast cancer: a phase II trial of the Clinical Screening Cooperative Group of the European …

B Chevallier, P Fumoleau, P Kerbrat… - Journal of clinical …, 1995 - ascopubs.org
PURPOSE This trial investigated the toxicity and efficacy of docetaxel as first-line
chemotherapy in women with heavily pretreated advanced breast cancer. PATIENTS AND …

[HTML][HTML] Effectiveness of chest physiotherapy in infants hospitalized with acute bronchiolitis: a multicenter, randomized, controlled trial

…, L De Pontual, S Larrar, R Epaud, B Chevallier… - PLoS …, 2010 - journals.plos.org
Background Acute bronchiolitis treatment in children and infants is largely supportive, but
chest physiotherapy is routinely performed in some countries. In France, national guidelines …

[HTML][HTML] Identification of the minimal combination of clinical features in probands for efficient mutation detection in the FBN1 gene

…, M Claustres, P Aegerter, B Chevallier… - European Journal of …, 2009 - nature.com
Mutations identified in the fibrillin-1 (FBN1) gene have been associated with Marfan
syndrome (MFS). Molecular analysis of the gene is classically performed in probands with …